Insights into the drug screening approaches in leishmaniasis

B Gopu, P Kour, R Pandian, K Singh - International Immunopharmacology, 2023 - Elsevier
Leishmaniasis, a tropically neglected disease, is responsible for the high mortality and
morbidity ratio in poverty-stricken areas. Currently, no vaccine is available for the complete …

Therapeutic interventions for countering leishmaniasis and chagas's disease: from traditional sources to nanotechnological systems

EB Souto, J Dias-Ferreira, SA Craveiro, P Severino… - Pathogens, 2019 - mdpi.com
The incidence of neglected diseases in tropical countries, such as Leishmaniasis and
Chagas's disease, is attributed to a set of biological and ecological factors associated with …

Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents

A Upadhyay, P Kushwaha, S Gupta, RP Dodda… - European Journal of …, 2018 - Elsevier
The high potential of quinoline containing natural products and their derivatives in medicinal
chemistry led us to discover novel series of 25 compounds for the development of new …

Photodynamic effect of zinc porphyrin on the promastigote and amastigote forms of Leishmania braziliensis

CG Andrade, R Figueiredo, KRC Ribeiro… - Photochemical & …, 2018 - Springer
Leishmaniasis is a neglected disease present in more than 88 countries. The currently
adopted chemotherapy faces challenges related to side effects and the development of …

In vitro antileishmanial and antitrypanosomal activity of compounds isolated from the roots of Zanthoxylum tingoassuiba

RS Costa, OP Souza Filho, OCS Dias… - Revista Brasileira de …, 2018 - SciELO Brasil
Abstract Five coumarins (5, 7, 8-trimethoxycoumarin (1), sabandin (2), cubreuva lactone (3),
5, 7-dimethoxycoumarin (5) and braylin (6)), seven furoquinoline alkaloids (isopimpinelin …

In-Vitro Evaluation of 52 Commercially-Available Essential Oils Against Leishmania amazonensis

L Monzote, I Herrera, P Satyal, WN Setzer - Molecules, 2019 - mdpi.com
Leishmaniasis is a neglected tropical disease caused by members of the Leishmania genus
of parasitic protozoa that cause different clinical manifestations of the disease. Current …

In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana

FJ Barrera-Téllez, FD Prieto-Martínez… - International Journal of …, 2023 - mdpi.com
Human leishmaniasis is a neglected tropical disease which affects nearly 1.5 million people
every year, with Mexico being an important endemic region. One of the major defense …

Eugenol derivatives with 1, 2, 3-triazole moieties: Oral treatment of cutaneous leishmaniasis and a quantitative structure-activity relationship model for their …

RR Teixeira, PAR Gazolla, MPG Borsodi… - Experimental …, 2022 - Elsevier
Leishmaniasis is a group of neglected vector-borne tropical diseases caused by protozoan
parasites of the genus Leishmania that multiply within phagocytic cells and have a wide …

Depot subcutaneous injection with chalcone CH8-loaded poly (lactic-co-glycolic acid) microspheres as a single-dose treatment of cutaneous leishmaniasis

AJ Sousa-Batista, W Pacienza-Lima… - Antimicrobial agents …, 2018 - Am Soc Microbiol
Conventional chemotherapy of cutaneous leishmaniasis (CL) is based on multiple
parenteral or intralesional injections with systemically toxic drugs. Aiming at a single-dose …

[PDF][PDF] Leishmaniose: Aspectos gerais relacionados com a doença, o ciclo do parasita, fármacos disponíveis, novos protótipos e vacinas

VR Blanco… - Revista Virtual de Química, 2017 - static.sites.sbq.org.br
A leishmaniose é uma doença negligenciada que possui a grande maioria dos casos
registrados em países subdesenvolvidos e assim como outras doenças negligenciadas …